Consequently, we propose that the NEAT1/miR‐454‐3p axis significantly contributes to the emergence of chemotherapy resistance in GBM, and our study offers valuable insights into potential targets and developing therapeutic approaches for managing this aggressive brain tumor. This evidence concerns the gene NEAT1 and glioblastoma.